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----------------------------------------------------------------------------------------------------------------, 
This study was undertaken to determine the clonality 
of lymphomatoid papulosis (LyP), its clonal relation-
ship to lymphomas, which occur at high frequency in 
LyP patients, and to define the cell lineage of Reed-
Sternberg-like cells in type A lesions of LyP. Punch 
biopsies of skin of 11 adult patients with LyP were 
analyzed for morphologic SUbtype of LyP, surface 
antigens, and clonal T-cell receptor (TCR) gene re-
arrangements. Clonal rearrangements were identi-
fied by semiquantitative polymerase chain reaction 
amplification and sequencing of TCR-/3 chain genes 
in nine patients and TCR-1' chain genes in two 
patients. A single dominant clone was detected in 
multiple separate LyP lesions, often of different his-
T he c10nality of separate lymphomatoid papulosis (LyP) lesions and their relationship to clinically asso-ciated lymphomas have not been studied extensively. Using the Southern blot technique, Weiss e/ al (1986) found one or more rea rranged bands, representing 
clonaUy expanded T cells, in individual lesions of five of six LyP 
patients, three of whom had an associated lymphoma. In the on ly 
patient in whom several LyP lesions could be studied, different 
rearrallgem ents were detected, suggesting that separate LyP les ions 
might contain different T cell clones . We also found clonal T ceIls 
in LyP lesions of four LyP patients, and in one patient the same 
rearrangemeLlt was detected in separate lesions removed 11 1110 
apart (Kadin ct ai , 1987). Similarly, Whittaker c/ III (1991) fOlmd 
identical rearrangements in separate LyP lesions of type B or mixed 
type A and B histology, but none in patients with pure type A 
lesions, which suggests that type A lesions Illight arise from a 
non-T, non-B cell type. 
The disparity in results of th ese studies could be due to the low 
sensitivity of the SOLlthern blot m ethod to analyze clonal T cells in 
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tologies, in nine patients. The same clone was de, 
tected in LyP lesions and the anaplastic large ce~ 
lymphoma (ALCL) of 2 patients and the mycosi, 
fungoides (MF) of 2 other patients. No dominan~ 
clone could be detected in one patient with Ly~ 
uncomplicated by lymphoma or in a second patiell~ 
with LyP and MF. A T-cell lineage was evident fo\ 
RS-like cells in cell culture and in type A leSions, 
These results show that multiple regressing skin Ie, 
sions and associated T cell lymphomas (MF anq 
ALCL) are clonally related in most LyP patients, 
which suggests that the disease in these patients wa\ 
initiated by a non-random genetic event. Key lVOI·dsl 
mycosis fll"goides. ] Illvest Dermatol 106:696-700, 1996 
LyP lesions which contain many inflammatory cells and only a lo\\, 
number of atypical lymphoid cells. Moreover, the Southern blo\ 
m e thod has limitations due to incomplete digestion of DNA, 
restriction fi·agment pol ymorphisms, and limited resolution 0t 
clonal populations in the gel. To overcome these difficulties and (1\ 
clarifY the clonali ty of LyP and its re lationship to maliguall\ 
lymphoma , we lIsed a more sensitive, specific approach based o~ 
polymerase chain reaction (PCR) amplification and sequencing 0t 
T-cell receptor (TCR) genes fi'olll multiple LyP lesions ofindivid\ 
ual patients and associated lymphomas. The results ofrer strOI1~ 
evidence that LyP is a clonal Iymphoproliferative disorder a.u~ 
indicate that regressing lesions of LyP are clonally related to th~ 
malignant lymphoma of most LyP patients. 
MATERJALS AND MET HODS 
Patients .Eleven adults, eight fen1ak ilnd three l1.1.alc. with dinic~ll a.lt~ 
pathologic features of Lyl' were srudi ed. All patients had recurrent SpOIH:l\ 
ncously regressing papular or paplllonccrol;c skin lesions, 2-1 2 111111 i~ 
diamcter, for 1-38 years, median 13 years. Five patients had ilddjtioD~ 
evidence of malignant lymphoma, either nodular progressive lesions 0 
anaplastic large cell lymphoma (ALCL) (patients 7 and 8) , or patch/plaqu~ 
lesions of mycosis fungoidc., (MF) (patients 9 ro 11) . 
Tissues Punch biopsies (4 - 6 111111) of skin were dividcd and fixed ill BS Ot, 
10% formalin for histology, fixed in 4°;', paraformaldehyde-Iys in-periodate, 
and snap-frozen for immunopathology (Muramoto and Kadin, 1987) , 0\ 
snap-frozen directl y for cryostat sections and extraction of RNA and DNA, 
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Histopathology Subtyping of LyP as typc A. type B, o r mixed typc A 
and B (A/B) was donc according to the criteria of Willcmze (Willcmze ct 
ai, 1982) . A diagnosis of ALCL was made for non-regress ing lesions with 
sheets of largc atypica l CD30 + cells that extended into the subcutis (Paulli 
el ai, 1995). A diagnosis of MF was made for stablc lesions containing 
epidermotTopic atypica l lymphocytes with convoluted nuclci. 
lnununophenotyping Par:.£I:in sections were labeled with monoclonal 
antibodies against lymphocyte activation antigens Ber-H2 (CD30) and 
Leu-M1 (CD15), B-cell antigen L26 (CD20). and leukocyte commolJ 
antigen (CD45). Frozen sections were labeled with monoclonal antibodies 
against CD30, CD15, CD20, IL2-R a chain (C D2S) and T-cell antigcns 
Leu-l (CDS), Leu-2 (CDS), Leu-3 (CD4), Leu-4 (CD3), UCHL-l 
(CD45RO), and T C R framework antigen (/3[1), with a 3-stcp iIl1l11unopcr-
oxidase techniquc utilizing streptavidin- ho rscradish perm .. ;dasc (Carton and 
Pedersen, 1989) . 
SelDi-quantitativc PCR Amplification ofTCR-/3 Chains Fot ana l-
yses ofTCR-/3 chains in 9 patients, 10-I.un frozen sections from each lesion 
were examined for atypical lymphocytes. After confirmation ofthc presence 
of atypical lymphocyt.cs . RN A was extracted using RNAzol-13 (TM Cinna 
Scientifi c, Friendswood, TX) and cDNA was synthesi zed using oligo-dT 
and MMTV reverse transcriptasc (GIDCO-BRL, Gra nd Island, NY). Usc of 
different V /3 genes was then determined by a semiquantita tive PC R method 
using a panel of oligonucleotide primers for each of 24 human V /3 families 
and a C/3 antisense primer (5'GCCTTTTCCCTGTGGGAGAT3'). T he 
primers for V/3 1-24 have been described previously (Blumberg cI ai, 1993; 
Gross et ai, 1994). Twenty-microliter reactions contained 10 pmol each of a 
V{3 primer "nd the C/3 primer. 0. 1 mg/ ml BSA , 0.2 mM dNTPs , 1.5 mM 
MgCI2 , and 0.5 unit Taq polymerase. Each cycle was 94 °C fo r 20 s. 55°C 
for 30 s and 72°C for 60 s. Aliquots of 5 J.l.1 were withdrawn after 30 cycles 
and dot blotted with a 32P-Iabeled in terna l C/3 antisense probe (S'GGCT-
CAAACACAGCGACCT3'). Quantitation was performed on a Molecular 
Dynamics Phosphorimager (Molecul il r Dynamics, Sunnyva le, CAl. 
Analysis of PCR-amplified TCR-/3 Chains by Polyacrylamide Gel 
Electrophoresis PC R amplified TCRs were reamplified using a nested 
32p cnd-I"be lcd "ntisense C/3 primer (5'GGCTCAAACACAGC-
GACCT3 '). Each 20-J.l.1 reaction contained 0.5 J.l.1 of amplified TCR fro m 
the q uan titativc PCR reactions, 50 ng of labeled C/3 primer, enzymc, 
nucleotides, and buffer. Amplification was for 22 cycles. PCR products 
were heat denatured and separated on 6% DNA-sequencing gels. The 
presen ce of dominant bands was confirmcd by repeating analyses at least 
three times using separate aliquots of cD NA. 
Direct Sequencing ofPCR-amplified TCR-/l Chains PC R products 
corresponding to dOl11 inant bands were excised from the gels, eluted by 
overnight incubation in 0.5 M ammonium acetate, 0.1% SDS. 0.1 mM 
EDTA, and etha nol-precipitatcd . After rea mplification with the particular 
V/3 and C/3 primer, direct sequencing was ca rried o ut on an Applied 
Biosystems 373A DNA sequencer, using Taq DNA polymerase and floures-
cen t dideoxYl1uclcotides (Applied Biosystcms, Foster ,C ity, CAl. 
Genomic DNA Extraction and peR Amplification of TCR-y Chai.ns 
For analysis of T C R-1' chains in two patients, genomic DNA was cxo'acted 
from 10-J.l.m sections of formalin-fixed, paraffin-embedded tissues using stan-
dard protocols (Wright and Manos, 1990). For PCR amplification of rear-
ranged TCR-1' segments. a two-step semi-nested protocol was designed. For 
prunary amplification an external primer for each of the two Vy subgroups 
(VyI and V1'Il) was used with a J1' pruner. fo llowed by amplification with an 
inte=al primer for each of the two V1' subgroups and the same J y plimcr. 
Primers fo r Vyl contained the sequences 5' TTCCCAn-GCAGCCAGT-
CAGA 3' and 5' GACTGGGTCATCTGCTGA(T)AATCAC 3 ' (correspond-
ing to conservcd extcmal and intem al V1'l-S sequences. respectively). and fo r 
V')'U 5' TTGGTITATITACTCCCTCCCAT 3' and 5' GGGGTACCTA-
GAGCAACCTCAAATTTCCA 3' (corresponding to cxternal and intemal 
V-y9 sequences, respectively) . J1' pruner sequences were 5' GTAATGATA-
AGCTTTGGTTCCGGGA 3', 5' GTGACAACAAGTGTTGTTCCACTG 
3', and 5' GAAGTTACTATGAGCTTAGTCCCT 3' for J1'P, J 1'1.2, and 
]1'P1.P2, respectively. Primary amplifIcation was perfonned with extemal 
primers V1'1 or V1'1l and pooled J 1' pruners. The 100-J.l.1 reaction mixtures 
contained 200 ng of each prinlcr and reagen ts at the sanlC concentrations as 
described fot TCR-/3 PCR. Five cycles were at 94°C for 1 min, 55°C fo r 1 min, 
an.d 72°C for 5 min, fo llowed by 20 cyclcs of 94°C for 20 s, 55°C for 30 s, and 
72°C for 1 min, with a fl11al 7-min extens.ion at 72°C. Semi-nested PCR 
amplification was perfollllcd with each of the intclllal V1'1 or V1'1l primers and 
each 0[321' end-labeled J1' primers 0 1'P.J1'1.2, andJ1'PI.P2) in a 20-J.l.1 reaction 
mixrure containing J - J.l.1 of the initial PCR product and the same concentration 
of o ther reagents. T hirty-five cyclcs at 94°C for 20 s, 55°C for 30 s, and 72°C 










F igure 1. V/37 is used by the m ajority o fT cells from a LyP type A 
lesion o f patient 1. Semiquantitative PC ll ampli fication of cDNA. x-axis . 
V/3 1-24; J'-axis , pixel va lue Xl0- S, proportional to cpm. 
for 1 min were fo lJowcd by a 7-min extension at 72°C. PC R products were 
heat-dcnatured and separated on 6% DNA-sequcncing gels. 
Cloning and Sequencing of TCR- y Chains PC R products were 
blun t-ended with T4 DNA polymerase. digested with Kp"] and ligatcd into 
Kp,,1 and SlII al sites of pBluescI;pt 11 KS +/- (Stratagene, La J olla, CAl· 
Colonies were scrccned with a ·'2P-Iabeled internal V1'1 probe (5 ' TCTAT-
TACTGTGCCACCT 3'), which hybridizcs to conserved sequences of 
V1' I- S. or with an intemal V1'1l probe (5 ' GTAGAGAAACAGGACAT-
AGC 3 ') . Scquencing of multiple isolates was carri ed out using the 
Sequenasc kit (United States Biochemicals, C leveland, 01-1). 
RESULTS 
LyP Cells Are Activated T Cells Resembling Tuttlor Cells o f 
HD or MF Six patie n ts (patients 1-6) had LyP un complicated by 
lymph o ma . T hree patients h ad o nly type A les ion s, two h ad type A , 
type B, and mixed type AlB lesions . and o n e h ad type A and mixed 
type A l B les io n s. Pa tie n t 7 with ALCL h ad coexisten t and prior 
lesions of LyP type A and p atch les.iollS con sistent w ith LyP type B 
or early MF. Patie nt 8 had an ALCL with sheets of Reed-Sternberg 
(RS)-like cell s followed by LyP lesion s of mixed type Al B histol-
ogy. Pa tien ts 9-11 h ad MF les ions as well as LyP type A. 
T he immullophe llotype of atyp ica l LyP cells was con sistent w ith 
th at of activated T lym p h ocytes (Kadin c/ ai, 1985). T he atyp ical 
cell s expressed CD4 in all but o n e case (patien t 11) in w hom a CDS 
phenotype was found . A som ewha t di fte re n t immuno phe notype 
was detected fo r the atypica l ce ll s in sep arate LyP lesio n s of fiv e 
patie nts (1 , 2, 3, 6, 7) , altho ug h these les io n s were subsequently 
found to be clonally re lated (see be low) . All les io n s of LyP type A 
o r ALCL had CD30 "' , CD25 '" la rge atyp ical cell s; in four patien ts 
o n e or more LyP type A lesions a lso contained large atypical 
CDls + cells. Lesions ofLyP type B or MF h ad few or n o CD30 + 
o r CD2s + cell s, an d no CD 1s + cell s. Lesions ofLyP mixed type 
Al B con ta in ed m oderate numbers ofCD30 + , CD2S + cell s, and nO 
CD1S + cells. 
Multiple Regressing Lesions o f Lymphottlatoid Papulosis 
Are CIon ally Relate d F rozen sections fro m les ions of patients 
1-5 were used to extrac t RN A and pre pare cDNAs. Sem iquanti-
tative PC R ampli ft ca tio n analysis indicated that V {37 was th e 
predominant V{3 expressed by T cells in an LyP les ion of patien t 1 
(Fig 1). To compare the V{37 transcrip ts of this and other lesions, 
the prec ise len gth of the V{37 transcripts was determined on DNA 
sequen cing gels. T his an alysis revealed a single V {37 transcript of 
ide ntica l size in each lesion , su ggesting th at the lesions were 
m o n oclon al (Fig 2 , lalles 1-3). To confirm that th e les ions were 
m o n oclonal , the dominant band from each les io n was excised, 
reamplifie d, and direc tl y sequ e n ced (Table I) . 
T h e cDN A from patients 2-5 were studied simil arly. T he results 
indica te that aU lesions from patien ts 2, 3, and 4 contained a sing le 
d o minan t T cell clon e (Table I) . In con trast, a dominant clon e was 
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Jy1 ,2 . DNA extracted from the fourth biopsy obt<lined in 1966 did 
not amplify with the primer set Vyl and ]yl,2. Successful amplifi, 
cation of a smaller DNA fragment was achieved by Llsing a primer 
located further 3' in Vy8 (5' TACTGGAAAATCTAATTGAA, 
CGTGAC 3'). To exclude the possibility of contamination, ,I new 
]yl,2 primer located 3' of the previous Jyl,2 primer was also u se~ 
(5 ' TTGGAAATGTTGAATICTTCCGATAC 3'). Sequencing at 
this PCR product confirm ed that it was identical to the V..., 
identified in later lesions (Table I) . Tllis fmding demonstrated that 
all LyP lesions of patient 6, separated by as much as 26 years , wer~ 
derived from a common T cell clone. T hus, the anatomjcally auq 
temporally separate les ions of five of six patients with LyP un conJ\ 
plica ted by lymphoma were monoclonal. 
Figure 2. The same dominant T - cell clone using V{37 is found in 
three LyP lesions froln patient 1 (Ialles t - 3), whereas two LyP 
lesions of patient 5 are polyclonal (Ialle 4, V{35; lalle 5, V(33) . TCR-{3 
transcripts wefe separated by size on polyacrylamide gels. All experiments 
were done in tripUcate using three separate aliquots of eD NA. 
Lesions of Lymphomatoid Papulosis Are Clonally Relate~ 
to Anaplastic Large Cell Lymphoma Two patients had Lyll 
and ALCL. In patient 7, a cell culture of atypical RS-like cells wa~ 
de rived from the ALCL biopsy . Thesc cells were aneuploid and haq 
marker chromosomes consistent wieh a monoclonal origin (U\ 
preparation). Semiquantitative PCR amplification with a panel at 
V (3 primers revealed that the Cllltured cells all llsed V {32. AnaJysi~ 
of frozen sections from the biopsy lIsed to generate this cell lil1~ 
showed that the dominant V(3 chain Llsed was also V(32 . Th~ 
lengths of the V (32 using TCR- (3 chains from the cu ltured cells anq 
the biopsy were compared and evidence for a single identical clOD~ 
ill lJitro and jll "j'I<1 was obtained (Fig 3) and confirmed by DN1\, 
sequencing (Table I) . 
not detected in patient 5. Semiquantitative PCR amplification 
analysis £i'om this patient did not reveal any dominant V(3s (data not 
shown) . Analysis of TCR N-regiol1 lengths in each lesion using 
several V (3s failed to detect the presence of a clonal population (Fig 
2 , lanes 4, 5; data not shown). 
Foot fomlalin-fixed, paraffin-embedded LyP lesions were avail-
able from patient 6. Genomic DNA from these tissues was ampli-
fied with primers specific for the TCR-y chain. One primer 
combination (V yI and J y1 ,2) generated a prominent band at exactly 
the sam e position in each of three anatomically separated lesions. 
Cloning and sequencing confi rmed that all three lesions contained 
To determine whether this clone was present in archival Lyi' 
lesions dating back 6 years, peR reactions were carried out with ~ 
32P_I'lbeled clone-specific primcr. T llis primer, based in the VD] 
junction, together with a V(32 primer, was used to amplifY DNA 
extracted from prior LyP lesion s. Figure 4 shows that PC1\ 
Patie nt 
No. 
Table I. DNA Nucleotide Sequences of Skin Lesions from Patients with LyP and Associated Lymphomas* 
Spccimcns Dingnosis/sitel date V{3/y N Jf3/ 
1. LyP A. thjgh , 1991 V{37 CAAGTTGATATGGGGCTAGCGGGATTC J{32. \ 
2. LyP AI)), thigh, 1991 V{37 CAAGTTGATATGGGGCTAGCGGGATTC J{32.\ 
3. LyP B, wrist, 1991 V{37 CAAGTTGATATGGGGCTAGCGGGATTC J{32 .1 
2 1. LyP A, back, 199 '1 V{35 GGAGGTGGAGAT J{31.S 
2. LyP B, back, 199 '1 V{35 GGAGGTGGAGAT J{3q 
3. LyP D, wrist, 1991 V{35 GGAGGTGGAGAT 1{31 .S 
4. LyP AlB, thumb, 1991 V{35 GGAGGTGGAGAT J{3l.~ 
3 1. LyP A, leg, 1984 V {35 AGACCCAGGACAGGGGCTACTTCG J{32./ 
2. LyP AlB , trunk. 1985 V{35 AGACCCAGGACAGGGGCTACTTCG J {32. 
4 1. LyP A, left forearm, 1988 V (38 CCTGAAGGAAGG ]/32.) 
2 . LyP A, right thigh , 1988 V{38 CCT GA AGGAAGG ]/32./ 
3. LyP A. right thigh. 1988 V{38 CCTGAAGGA AGG J{32. 
4 . LyP A, left knee, 1988 V{3!J CCTGAAGGAAGG J/32./ 
5. LyP A, I990 V{38 CCTGAAGGAAGG J /32 .) 
6 1 . LyP A, back.! 992 Vy8 TTCT Jyn 
2. LyP A, abdomen, 1992 V 1'8 TTCT J Y 1. ~ 
3. LyP A, left thigb, 1992 VI'8 TTCT ] yn 
4. LyP A, left arm. 1966 Vy8 TTCT J ')'1., 
7 1. LyP A, right thigh, 1988 V{32 ACTAGCGGGAGAAGATATTTTAAC J{32. \ 
2. LyP 13 , left forearm, 1988 V{32 ACTAGCGGGAGAAGATATTTTAAC ) {32.\ 
3. LyP A. right forearm , 1989 V{32 ACTAGCGGGAGAAGATATTTTAAC J f32 .1 
4. LyP A, right forearm. 1992 V{32 ACTAGCGGGAGAAGATATTTTAAC )/3-.1 
5. MCL. right forearm , 4/1993 V{32 ACTAGCGGGAGAAGATATTTTAAC J{32. \ 
6. ALCL, ri ght forearm, 11/1 993 V{32 ACTAGCGGGAGAAGATATTTTAAC ]132.1 
8 l. ALCL, abdomen, 1990 V{35 TTACAGGCACAC Jf32. 
2. LyP AlB, abdomen,1991 V{35 TTACAGGCACAC Jf3-.' 
9 1. LyP A. back. 1984 V{36 TTAGTTAGCGGGGGGTCGGTACCT J{32 .~ 
2. LyP A, chest, 1987 V{36 TTAGTTAGCGGGGGGTCGGTACCT J {32 .~ 
3 . MF, right lat. trunk, 1993 V{36 TTAGTTAGCGGGGGGTCGGTACCT J{32.~ 
11 1. LyP A, right leg. 1984 Vy2 TT ] yP~ 
2. ,L-yP A, lower back, 1984 Vy2 TT ] rP2 
3. MF, buttock, 1984 Vy2 TT j r1'2 
• Data 0 11 paticllts 5 and '10 arc 11 0t included. Because o f the poly clonal nature of LyP lesio n, in patient 5. no dearly readable sequences were obtained by direct sequencing 1 
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Figure 3. The ALCL biopsy from patient 7 (/alle 1) and dte cell 
culture generated thereof (lalle 2) contain the same dominant 
T - cell clone using V(32. In contrast, amplifications of the ALCL biopsy 
eDNA with V(33 (falll' 3), V(38 ( Inlle 4), and V(313 ( InIIl' 5) gcncrated ITlultiplc 
band s of sill1iJar intensity, suggestive of a polyd onal T cel l population. 
products of precisely the correct size were amplified from each LyP 
lesion, indicating that the ALCL clo ne was present in these samples. 
No product co uld be detected in periph eral blood lymphocytes 
fro m this patient o r a seri es of negative contro l samples. As a further 
control, an additional V {32 primer loca ted furth e r 5' was used 
roge ther with the prime r in the VD] junction. These prime rs 
similarly amplified the TCR of the ALCL clo ne speci.ficaJly from 
tbe a rcm val LyP lesions . T hese results demonstrate that the domi-
nant T cell clone in the ALCL was present in the LyP lesio ns for 6 
years and was represented by RS-like cells rather than tumor-
infiltrating lymphocytes. 
Similar results were obtaine d in patient 8, who had LyP lesions 
one year afte r experie ncing an ALCL on the abdome n . An identica l 
dominant T-cell clone was identified in the ALCL and an LyP 
lesion from this patient (Table I) . 
Lesions of Lymphomatoid Pap ulosis Are CIon ally Related 
to Mycosis FUl1goides Frozen tissues were avai lable fi'om the 
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Figure 4. The same dominant T cell clone is present in archival 
paraffin-embedded ALCL and LyP lesiolls of patient 7. Gcnomic 
DNA extractcd frol1ll11ultipl e lesions (tnll es 3- 7) or cDNA (fnll cs 1, 2,8) was 
amplificd with a V(32 primer and a 32P_labclcd c1onc-specific primcr and the 
prod ucts loaded onto polyacrylamide gel. 
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Figure 5. The same dominant T-cell clonc is prcsent in LyP lesions 
and MF ofpaticllt 9. T hree separatc cDNA aliquots each of two LyP type 
A lesions (In lie 1, 2) and an MF lesion ( Inlle 3) were ampli ficd with a V(36 
primer and a J2P-labded intcrnal C(3 primer. T he PC R. products were 
loaded onto polyacrylamide gel. 
M F and LyP lesions of patients 9 and 10 and V{3 gene use was 
analyzed . A common d ominant clone using V{36 was detected in 
both the MF and LyP lesions of patie nt 9 (Fig 5 , Table I); 
however a dominant T-cell clone cou ld not be detecte d consis-
te ntly in the MF o r LyP lesions of patient 10. Patient 11 had o nly 
paraffin-e mbedded tissue ava ilable for an alysis. To compar e the 
clonal relatio nship between LyP alld MF in this patien t, TCR-')I 
ch ains fi'om the MF lesion were PCR- amplified. A single do minant 
clo nc using Vy2 and] ')IP2 was identi fied and sequen ced (Table I) . 
A clone- specific prime r togethe r with a Vy2 prime r showed that 
the two ava ilable LyP lesions fi'om this patient con ta ined the same 
TCR- y rea rra ngement as the M F lesion . 
DISCUSS ION 
Southe rn blot analyses in LyP have de monstrated clonal rearrange-
m ents of TCR genes in approximatcly 65% of cases (Weiss el ai, 
1986; Kadin ct ai, 1987; Whittake r e/ ai, 1991 ; Zelickson et ai, 1991; 
Parks et ai , 1992). A recent PCR-based study showed clonal TCR -')I 
rearrangements in isolated lesions fi'om 7 of 10 patie nts with LyP 
type A (Theodorou CI ai, 1995) . T lu'ee studies using PCR amplifi-
cation and seque ncing of TCR- ')I gen es showed a commo n clonal 
origin ofLyP skin lesions and eithe r CD30 large celllymphom3 o r 
ea rl y patch / pl aque M F in four patients (Volken andt c/ ai, 1993; 
Bottaro el ai, 1994; Wood c/ ai, 1995). 
T his study exa mined a series of patie nts with mul t iple lesions and 
demonstra tes that in m ost cases (9 of 11 or 82%) LyP is a 
m o noclonal disorde r arising fi'o m a sing le t ransformed T cell . 
Moreover, th e failure to detect a dominant clone in two cases does 
not n ecessarily re Rect the absence of such clones. T he panel of 
primers will not amplify all V {3 genes and may ampli fy som e clones 
inefri ciently. Such clones wou ld be missed beca use the V{3 they use 
would appear to be expressed at very low frequency o r the 
N -regio n le ngth an al ysis would not show clear eviden ce of a 
do minant band . Other genetic even ts, such as dele tion of t he 
rearranged TCR or clonal e xpansion p rior to TCR gene rearrange-
m ent (Davis ct ai, 1992), could also ex pl ain the absence of a 
dominant TCR . It rem ains poss ible. however , th at a sm all subset of 
LyP cases have a distinct etio logy and arc trul y po lyclona l. 
This study indicates that the RS-like ce ll s in LyP are commo nl y 
d el-ived from T lymphocytes, a tinding that had been difficu lt to 
discern in previo us studies using less sensiti ve m ethods (Whittaker 
c/ ai, 1991) . T he T - cell lineage of R S-likc ce lls was partic ularly 
clear in case 7, in w hich RS-like cells ill c ul ture were shown to be 
derived fi'om a dominant T cell clone in a se';es of LyP and ALCL 
skin lesions. In several pati ents, the sam e clone was found in l es ions 
of different histologies and immunophenorypcs. T hese variable 
histo log ies and iml11unophe notypes m ay be due to difFerences in 
local cytokine productio n . TL-7 pro duced by keratinocytes (HeuRer 
700 C HOTT ET AL 
et (/1, 1993) and IL-2 by tumor-infiltrating lymphocytes (Reinhold ct 
aI, 1991.) couJd act synergisticaJly to activate the LyP clone, 
resulting in the transformation of cerebriform lymphocytes in LyP 
type B lesions and MF to RS-like imJJ1ulloblasts in LyP type A 
lesions and ALCL (Kadin ct aI, 1984). The activated T-cell clone 
can elaborate IL-8, TNl~-a and TGF-J3, which attract neutrophils 
characteristic of type A lesions (Leonhard cl aI, 1991; Ming e/ aI, 
1987; Reiban et aI, 1991). TGF-J3 co uld mediate the regressiou and 
fibrosis typical of LyP (Kadin et (/1, 1994a,b; data not shown). 
The detection of the same T-cell clone in LyP and associated 
lymphomas indicates that LyP is a clonal disorder presumably 
initiated by alteration of a particular protein i.n a T lineage 
lymphocyte. The nature of this alteration is currently unknown but 
is clearly of great interest because it is likely to be involved in some 
cases of Hodgkin's disease and non-Hodgkin's lymphoma. The 
development of lymphoma in only a minodty of LyP patients 
further indicates that subsequent genetic events cause progression 
to malign,U1t lymphoma (Nowell, 1986; Ludwig, 1994). One such 
event apparentl y is a mutation of the type II receptor for TGF-J3, 
which fa cilitates growth of the LyP clone (Kadin e( aI, 1994; Knaus 
el aI, submitted). It is like ly that additional genetic alterations wilJ be 
identified, since we and others have demonstrated multiple chro-
mosomal abnormalities in LyP and LyP-associated lymphomas 
(Espinoza et a/, 1985; Parks et aI, 1992; Peters e1 a/, 1995). 
T his stlldl' ",ns slI)l)lorted iJl' Nalinllnllllslilllles '!.fHeall.h G ralll RO"l-CA 54062 
10 Dr. Kndill nlld Dr. Balk, allli SIIPPOI1./i'Olll Ihe Belh Israel Patho{o"~)' FOlllllialioll 
to Dr. Karlill. Dr. CllOlI received slIpporl J/"{/II/. Ille Max [(llIle FOlllldalioll , IIIC., Nelli 
York, NY. Dr. VO lldcrhcid is slIpPMled by Ihe Leollard allll Rllth L eville Skill 
Research Flllld. T"" alll"ors appreciale jlalielll el1alllatioll mid biopsies pC([cll"lll cd by 
Drs. J~ffi·ey Dover "lid HOllfard Kill!. 
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